Grace E. Colon's most recent trade in Voyager Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Grace E. Colon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Grace E. Colon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Caredx Inc | Grace E. Colon | Director | 16 Jun 2023 | 29,136 | 29,136 | - | - | Common Stock | ||
| Caredx Inc | Grace E. Colon | Director | 16 Jun 2023 | 18,844 | 23,708 (0%) | 0% | 0 | Common Stock | ||
| Voyager Therapeutics Inc | Grace E. Colon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Grace E. Colon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) |